Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-citrulline in Prevention of Pregnancy Associated Hypertension in Nulliparous Women
NCT04979793Phase 1Terminated
- Sponsor
- The University of Texas Medical Branch at Galveston
- Start
- Jul 2021
- Primary completion
- Dec 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in pregnancy-induced hypertension (PIH) comparing Placebo with Daily L-citrulline (2 arms). Primary endpoint: Incidence of pregnancy induced hypertension. Started Jul 2021; status: terminated.
02
Drugs
citrulline
03
Conditions
pregnancy-induced hypertension (PIH)
Beyond the preview
Go deeper on NCT04979793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04979793.